Italian regulator slams simvastatin-maker Krebs for GMP deviations
APIs made by Krebs Biochemicals and Industries at its facility in Visakhapatnam, India pose a ‘critical risk’ to public health according to Italian regulators.
Archives for May 22, 2016
Albumedix tech key to Chinese efforts to develop once-a-week diabetes drug
Recombinant albumin supplier Albumedix will help Hebei Changshan Biochem Pharma develop a once-a-week diabetes treatment.
update
Biotrial criticised over fatal Phase I study by France's social affairs inspectorate
French investigators reviewing the Phase I trial in which one volunteer died and five others were hospitalized in January have criticised CRO Biotrial over how it conducted the study.
Patient collaboration barriers and the 'willingness to iterate forever'
Patients must be more involved in trials according to ex Google Chief Health Strategist, who told sponsors and CROS that increasing engagement is key to moving forward.
Crown Bioscience launches high throughput service platform
Crown Bioscience has launched an oncology service platform to improve preclinical studies using patient-derived xenograft (PDX) models.
Olon SpA to buy Infa Group
Italian API firm Olon SpA has signed a definitive agreement to buy Infa Group in a deal designed to strengthen its portfolio.
IMA: Angina drug API firm JP Laboratories cannot keep Daund plant up to code
Indian API maker JP Laboratories is unable to sustain GMP compliance at its facility in Daund, Maharashtra according to the Italian Medicines Agency (IMA).